Oluyemi  Okupe net worth and biography

Oluyemi Okupe Biography and Net Worth

Yemi Okupe is our Chief Financial Officer. He brings to Hims & Hers a wealth of experience in financial leadership positions at high-growth, B2C companies that have successfully transformed entire industries. From 2019 to 2021, Yemi served as a Divisional CFO at Uber, first in charge of UberEats – one of the largest food delivery platforms in the world – and later of Uber’s global mobility unit, which included ridesharing, transit, and micro mobility services across 60 countries. Yemi has also served in a number of financial leadership positions at eBay and PayPal – including as Divisional CFO of Braintree – and Google, where he was the finance lead for Google Payments and Google Express. He is a graduate of Stanford Business School.

What is Oluyemi Okupe's net worth?

The estimated net worth of Oluyemi Okupe is at least $2.78 million as of October 14th, 2024. Mr. Okupe owns 145,763 shares of Hims & Hers Health stock worth more than $2,778,243 as of October 30th. This net worth estimate does not reflect any other investments that Mr. Okupe may own. Learn More about Oluyemi Okupe's net worth.

How do I contact Oluyemi Okupe?

The corporate mailing address for Mr. Okupe and other Hims & Hers Health executives is 2269 CHESTNUT STREET SUITE 523, SAN FRANCISCO CA, 94123. Hims & Hers Health can also be reached via phone at 415-851-0195 and via email at [email protected]. Learn More on Oluyemi Okupe's contact information.

Has Oluyemi Okupe been buying or selling shares of Hims & Hers Health?

In the last ninety days, Oluyemi Okupe has sold $5,675,364.37 in shares of Hims & Hers Health stock. Most recently, Oluyemi Okupe sold 269,739 shares of the business's stock in a transaction on Monday, October 14th. The shares were sold at an average price of $20.31, for a transaction totalling $5,478,399.09. Following the completion of the sale, the chief financial officer now directly owns 145,763 shares of the company's stock, valued at $2,960,446.53. Learn More on Oluyemi Okupe's trading history.

Who are Hims & Hers Health's active insiders?

Hims & Hers Health's insider roster includes Jack Abraham (Major Shareholder), Melissa Baird (COO), Soleil Boughton (Insider), Patrick Carroll (Insider), Michael Chi (Chief Commercial Officer), Andrew Dudum (CEO), Spencer Lee (CFO), Oluyemi Okupe (CFO), Christopher Payne (Director), and David Wells (Director). Learn More on Hims & Hers Health's active insiders.

Are insiders buying or selling shares of Hims & Hers Health?

In the last year, Hims & Hers Health insiders bought shares 1 times. They purchased a total of 110,000 shares worth more than $1,951,763.00. In the last year, insiders at the sold shares 76 times. They sold a total of 2,649,244 shares worth more than $43,437,910.49. The most recent insider tranaction occured on October, 29th when insider Soleil Boughton sold 2,339 shares worth more than $54,171.24. Insiders at Hims & Hers Health own 17.7% of the company. Learn More about insider trades at Hims & Hers Health.

Information on this page was last updated on 10/29/2024.

Oluyemi Okupe Insider Trading History at Hims & Hers Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/14/2024Sell269,739$20.31$5,478,399.09145,763View SEC Filing Icon  
10/7/2024Sell9,868$19.96$196,965.28195,988View SEC Filing Icon  
9/20/2024Sell12,651$16.79$212,410.29211,000View SEC Filing Icon  
9/3/2024Sell11,609$14.60$169,491.40181,469View SEC Filing Icon  
6/25/2024Sell11,546$22.21$256,436.66177,449View SEC Filing Icon  
6/6/2024Sell98,635$21.42$2,112,761.70146,839View SEC Filing Icon  
3/20/2024Sell9,912$15.82$156,807.84168,627View SEC Filing Icon  
2/12/2024Sell31,363$10.03$314,570.89156,721View SEC Filing Icon  
2/9/2024Sell8,509$10.03$85,345.27161,699View SEC Filing Icon  
12/20/2023Sell6,784$8.58$58,206.72170,208View SEC Filing Icon  
11/21/2023Sell6,698$7.62$51,038.76144,284View SEC Filing Icon  
9/20/2023Sell6,794$6.28$42,666.32150,982View SEC Filing Icon  
8/21/2023Sell6,698$6.92$46,350.16125,016View SEC Filing Icon  
3/17/2023Sell15,720$9.82$154,370.4099,013View SEC Filing Icon  
See Full Table

Oluyemi Okupe Buying and Selling Activity at Hims & Hers Health

This chart shows Oluyemi Okupe's buying and selling at Hims & Hers Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Hims & Hers Health Company Overview

Hims & Hers Health logo
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
Read More

Today's Range

Now: $19.06
Low: $18.63
High: $21.86

50 Day Range

MA: $17.89
Low: $13.65
High: $23.59

2 Week Range

Now: $19.06
Low: $5.76
High: $25.74

Volume

25,715,605 shs

Average Volume

8,251,232 shs

Market Capitalization

$4.09 billion

P/E Ratio

238.28

Dividend Yield

N/A

Beta

1.06